Trial to Investigate GZ21T in Healthy Volunteers

Clinical trial NCT06888362 · COMPLETED

Trial details

NCT number: NCT06888362
Sponsor: Genzada Pharmaceuticals USA, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Actinic Keratosis

Start date: 2024-08-19
Primary completion: 2025-03-31
Enrollment: 41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.